Developers Land $239M Construction Loan For Somerville Lab, Multifamily Project

Union Square Somerville
Courtesy of USQ
The Union Square Life Sciences And Residential Development Proposed By A Joint Venture.

A Somerville development set to reshape the suburb has received $239M in funding to begin construction.

A joint venture among four developers secured the financing from Bank OZK last month for a 194K SF life sciences facility and 450-unit residential tower, broker JLL announced Monday. The project is expected to deliver 2.4M SF across a mix of uses along Prospect Street, walking distance to Kendall Square, the developers said.

The venture consists of Magellan Development Group, RAS Development, Cypress Equity Investments and USAA Real Estate. Bank OZK provided $120M for the housing development and $119M for the remaining development known as USQ, according to South Middlesex County records posted last month. A JLL representative declined to comment on the funding.

“A new Class A life sciences building will anchor the neighborhood and create opportunities for the next great concentration of life sciences and technology companies to flourish,” RAS Development partner Greg Karczewski said in a statement.

The development takes a significant step toward groundbreaking three years after the Somerville Board of Aldermen voted to approve zoning changes for the site. The project, currently a vacant lot across the square of restaurants and retail, will rise over the MBTA’s Green Line extension, currently under construction through the neighborhood.

The move is the latest sign of life sciences momentum in the neighborhood becoming an alternative for developers seeking space outside of the crowded Kendall Square. BioMed Realty Trust recently announced closing on a massive site near Assembly Row.

Months earlier, DLJ Real Estate Capital Partners and Leggat McCall Properties announced the topping off of the 290K SF 101 South St., which is blocks away in the neighborhood. That structure was built with another $140M Bank OZK loan in 2019. A bank executive last week in an earnings call said the lender has “broke out for the first time” in life sciences lending, concentrated in the Boston-Cambridge submarket.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

140-Acre Attleboro Golf Course Hits Market, Pitched For Redevelopment

Why Research Triangle Park Life Sciences Is Turning Toward Manufacturing And Flexible Spaces

Alexandria Sells Stakes In Megacampuses To Weather Life Sciences Downturn

Nonprofit Developer Buys Mattapan Site For Affordable Housing: The Boston Deal Sheet

Downtown Office Tower Sells At Foreclosure Auction For $260M

AI Safety Nonprofit Takes 82K SF At BlackRock's King's Cross Campus

JLL Sues Ex-Life Sciences Leader, Alleging Breach Of Noncompete

FoxRock Buys Quincy Office At 78% Discount After Luring Tenant Away

Development Constraints In Massachusetts Push More Investors To Southern New Hampshire

Liberty Mutual Plans New Office Project To Consolidate HQ: The Boston Deal Sheet

Copper Mill Sues Partners Over Collapsed Deal For 750-Unit Dorchester Project